Article
Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators.
International journal of cancer - 1 Jan 2008
Ellinger Jörg, Bastian Patrick J, Haan Kim I, Heukamp Lukas C, Buettner Reinhard, Fimmers Rolf, Mueller Stefan C, von Ruecker Alexander
Abstract excerpt
Our study was designed to evaluate Cell-Free DNA in sera of prostate cancer (PCA) patients as a useful biomarker. Real-time PCR was used to amplify a <200 bp PTGS2 DNA fragment that biochemically characterizes apoptosis and a larger >250 bp Reprimo DNA fragment that defines mostly other cell death entities. The apoptosis index (AI) expresses the ratio of PTGS2 to Reprimo DNA fragments. GSTP1 hypermethylation was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
